TriSalus Life Sciences Inc. (TLSI) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TriSalus Life Sciences In...

    NASDAQ: TLSI · Real-Time Price · USD
    4.63
    0.01 (0.22%)
    At close: Oct 06, 2025, 1:24 PM

    TriSalus Life Sciences Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4 -3.79 -6.29 -10.7
    PEG Ratio
    		 0.09 -0.09 -0.09 -0.00
    PS Ratio
    		 4.51 12.08 23.95 36.75
    PB Ratio
    		 -5.13 -8.62 -1.68 9.99
    P/FCF Ratio
    		 -3.22 -4.37 -8.97 -12.89
    P/OCF Ratio
    		 -3.25 -4.42 -9.19 -13.6
    OCF/S Ratio
    		 -1.39 -2.73 -2.61 -2.7
    Debt / Equity Ratio
    		 -0.91 -0.06 -0.01 0.02
    Quick Ratio
    		 1.63 1.25 0.49 5.31
    Current Ratio
    		 2.02 1.42 0.53 5.51
    Asset Turnover
    		 1.23 0.72 0.56 0.22
    Interest Coverage
    		 -11.7 -3.38K -36.44K -13.65
    Return on Equity
    		 1.28 2.28 0.27 -0.93
    Return on Assets
    		 -1.39 -2.29 -2.15 -0.76
    Return on Invested Capital
    		 -2.55 -4.61 3.79 -0.76
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.86 0.86 0.82 0.86
    Net Profit Margin
    		 -1.13 -3.19 -3.81 -3.43
    Pretax Profit Margin
    		 -1.02 -3.19 -3.81 -3.43
    Operating Profit Margin
    		 -1.23 -2.93 -2.94 -2.86
    FCF Margin
    		 -1.4 -2.76 -2.67 -2.85
    EBITDA Margin
    		 -1.23 -3.15 -3.77 -2.81

    Add to Watchlist